Milestone Scientific (MLSS) Cash from Investing Activities (2010 - 2026)
Milestone Scientific's (MLSS) quarterly Cash from Investing Activities came in at -$1632.0 in Q1 2026, down 25.15% year-on-year from -$2180.5 in Q1 2025, and up 47.63% quarter-over-quarter from -$3116.0 in Q4 2025.
Milestone Scientific (MLSS) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Milestone Scientific has disclosed Cash from Investing Activities across 17 years of filings, most recently posting -$1632.0 for Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$1632.0, down 25.15% year-over-year; the trailing twelve-month figure through Mar 2026 was -$15452.0 (down 101.61% YoY), and the FY2025 annual result was -$15124.0, down 100.51% from the prior year.
- Cash from Investing Activities came in at -$1632.0 for Q1 2026 at Milestone Scientific, up from -$3116.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $2.4 million in Q2 2023 to a low of -$4.4 million in Q1 2023.
- The 5-year median for Cash from Investing Activities is -$3528.0 (2024), against an average of -$2067.1.
- Peak annual rise in Cash from Investing Activities reached 2881311.76% in 2023, while the deepest fall reached 12054.75% in 2023.
- Milestone Scientific's Cash from Investing Activities stood at -$4700.0 in 2022, then slumped by 10842.6% to -$514302.0 in 2023, then surged by 99.31% to -$3528.0 in 2024, then advanced by 11.68% to -$3116.0 in 2025, then jumped by 47.63% to -$1632.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$1632.0 (Q1 2026), -$3116.0 (Q4 2025), and -$6232.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Milestone Scientific | 28.92 Mn | 27.73 Mn | 1.56 Mn | -1,632.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,632.00 |
| Mar 31, 2026 | -1,632.00 |
| Dec 31, 2025 | -3,116.00 |
| Dec 31, 2025 | -3,116.00 |
| Sep 30, 2025 | -6,232.00 |
| Sep 30, 2025 | -6,232.00 |
| Jun 30, 2025 | -4,472.00 |
| Jun 30, 2025 | -4,472.00 |
| Mar 31, 2025 | -1,304.00 |
| Mar 31, 2025 | -1,304.00 |
| Dec 31, 2024 | -3,528.00 |
| Dec 31, 2024 | -3,528.00 |
| Jun 30, 2024 | 965,514.00 |
| Jun 30, 2024 | 965,514.00 |
| Mar 31, 2024 | 2.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | -514,302.00 |
| Dec 31, 2023 | -514,302.00 |
| Sep 30, 2023 | -475,494.00 |
| Sep 30, 2023 | -475,494.00 |